DIN 02541742 — MYFEMBREE 40 MG; 1 MG; 0.5 MG
MYFEMBREE is a tablet of Estradiol / Relugolix / Norethindrone Acetate marketed by KNIGHT THERAPEUTICS INC.. The full Estradiol / Relugolix / Norethindrone Acetate monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02541742
- Brand name
- MYFEMBREE
- Active ingredient
- Estradiol / Relugolix / Norethindrone Acetate
- Strength
- 40 MG; 1 MG; 0.5 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- KNIGHT THERAPEUTICS INC.
- Health Canada status
- MARKETED
- Drug class
- Gonadotropin-releasing hormone (GnRH) receptor antagonist with estrogen/progestin add-back therapy
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.